Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Am J Med Sci. 2013 Jul;346(1):10.1097/MAJ.0b013e3182648740. doi: 10.1097/MAJ.0b013e3182648740

Table 1.

Demographic and related information for patients studied

Patient Gender/Age (yr) Diagnosis* Disease Duration (yr) Remission& (mo) Reactivation? Joint Biopsied Current Therapy Previous Therapies
1 F/43 ReA 6.0 6 yes left knee NSAID, prednisone methotrexate same
2 F/50 ReA 3.5 3 yes right knee hydrocodone/acetominophen NSAID, etanercept, sulfasalazine, methotrexate
3 M/58 ReA 9.0 96 no left knee none NSAID, etanercept, methotrexate, sulfasalazine
7 M/57 ReA 34 96 yes right knee naproxen, rifampin erythromycin NSAID, sulfasalazine, multiple antibiotics
*

Abbreviation is: ReA, reactive arthritis

&

Duration of remission in the joint biopsied